Toledano Miranda Jayne

Track record

How each disclosed position did against the S&P ~6 months later

The outcome curve and every position's resultPro →

-13.9%

median move per position

+6.6%

S&P 500 median, same spans

0 of 1

beat the S&P ~6mo later

Disclosed positions

Estimated from their latest filings — positions may have changed since

Estimated positions from their latest filingsPro →

Activity

Open-market buy & sell volume

BuySell

Total +$19.9K bought

All filings on record

Every Form 4 transaction we track for this filer

All6Buys1Sells0

Stock	Transaction	Date	~6mo vs S&P
DERMJourney Medical Corp	Grant — · 50,000 sh	2026-07-01	—
ENTXEntera Bio Ltd.	Buy $19.9K · 11,000 sh	2025-12-29	—
DERMJourney Medical Corp	Grant — · 20,000 sh	2025-08-05	—
ENTXEntera Bio Ltd.	Grant — · 43,860 sh	2025-07-16	—
ENTXEntera Bio Ltd.	Grant — · 136,842 sh	2025-07-16	—
DERMJourney Medical Corp	Grant — · 7,173 sh	2025-06-25	—

DERMGrant

2026-07-01 · Journey Medical Corp

50,000

—

ENTXBuy

2025-12-29 · Entera Bio Ltd.

$19.9K

—

DERMGrant

2025-08-05 · Journey Medical Corp

20,000

—

ENTXGrant

2025-07-16 · Entera Bio Ltd.

43,860

—

ENTXGrant

2025-07-16 · Entera Bio Ltd.

136,842

—

DERMGrant

2025-06-25 · Journey Medical Corp

7,173

—

6 filings·Every Form 4 on record, with outcomesPro →

Filing in the same companies

Other insiders active in these names in the last 3 years

GG

Germano Geno J

ENTX · last 2026-08-07

HN

Herskowitz Neil

DERM · last 2026-06-25

PM

Pearce Michael Cooper

DERM · last 2026-06-25

SJ

Smith Justin Adam

DERM · last 2026-06-25

RS

Rubin Steven D

ENTX · last 2026-02-12

TH

Taitel Haya

ENTX · last 2026-02-10

Outcomes measure each position — the first buy in a stock and every buy within 182 days — against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.